翻訳と辞書 Words near each other ・ Retrograde pyelogram ・ Retrograde signaling ・ Retrograde tracing ・ Retrograde ureteral ・ Retrograde urethrogram ・ Retrograss ・ Retrogreen ・ Retrogression ・ Retrogression heat treatment ・ RetroHash ・ Retroinguinal space ・ Retrolisthesis ・ Retromammary space ・ Retromandibular vein ・ Retromer ・ Retrometabolic drug design ・ Retromolar space ・ RetroN ・ Retron ・ Retronecine ・ Retronym ・ Retrop, Oklahoma ・ Retroperistalsis ・ Retroperitoneal fibrosis ・ Retroperitoneal hemorrhage ・ Retroperitoneal lymph node dissection ・ Retroperitoneal space ・ Retropharyngeal ・ Retropharyngeal abscess ・ Retropharyngeal lymph nodes Dictionary Lists mini英和辞書 mini和英辞書 Webster 1913 Latin-English FOLDOC Wikipedia English ウィキペディア

翻訳と辞書　辞書検索 [ 開発暫定版 ] スポンサード リンク Retrometabolic drug design ： ウィキペディア英語版 Retrometabolic drug design In the field of drug discovery, retrometabolic drug design is a strategy for the design of safer drugs using either a soft drug or targeted drug delivery approaches. The phrase retrometabolic drug design was coined by Nicholas Bodor. The method is analogous to retrosynthetic analysis where the synthesis of a target molecule is planned backwards. In retrometabolic drug design, metabolic reaction information of drugs is used to design parent drugs whose metabolism and distribution can be controlled to target and eliminate the drug to increase efficacy and minimize undesirable side effects. The new drugs thus designed achieve selective organ and/or therapeutic site drug targeting and produce safe therapeutic agents and safe environmental chemicals. These approaches represent systematic methodologies that thoroughly integrate structure-activity (SAR) and structure-metabolism (SMR) relationships and are aimed at designing safe, locally active compounds with improved therapeutic index (ratio of benefit vs. side effect). == Classification == The concept of retrometabolic drug design encompasses two distinct approaches. One approach is the design of soft drugs (SDs),〔 new, active therapeutic agents, often isosteric or isolelectronic analogs of a lead compound, with a chemical structure specifically designed to allow predictable metabolism into inactive metabolites after exerting their desired therapeutic effect(s). The other approach is the design of chemical delivery systems (CDSs).〔 CDSs are biologically inert molecules intended to enhance drug delivery to a particular organ or site and requiring several conversion steps before releasing the active drug. Although both retrometabolic design approaches involve chemical modifications of the molecular structure and both require enzymatic reactions to fulfill drug targeting, the principles of SD and CDS design are distinctly different. While CDSs are inactive as administered and sequential enzymatic reactions provide the differential distribution and ultimately release the active drug, SDs are active as administered and are designed to be easily metabolized into inactive species. Assuming an ideal situation, with a CDS the drug is present at the site and nowhere else in the body because enzymatic processes destroy the drug at those sites. Whereas, CDSs are designed to achieve drug targeting at a selected organ or site, SDs are designed to afford a differential distribution that can be regarded as reverse targeting. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Retrometabolic drug design」の詳細全文を読む スポンサード リンク 翻訳と辞書 : 翻訳のためのインターネットリソース Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.